CHRNA5 and early-onset autosomal dominant Alzheimer disease: This combination suggests neuroprotective roles of CHRNA5 in β-amyloid pathology and makes CHRNA5 a target for therapies aiming to improve neuron survival in Alzheimer’s disease.